The US Food and Drug Administration (FDA) issued a new report Wednesday that summarizes a recent public workshop aimed at evaluating inclusion and exclusion criteria in pharmaceutical clinical trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,